Early fallopian tube cell changes were found in a high‑risk patient. A live tissue bank and organoid system will help explore ...

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

A woman who was in the best shape of her life before being diagnosed with a 'rare' form of cancer has spoken out about her ...

Eggs and embryos from people with polycystic ovary syndrome have altered patterns of so-called epigenetic tags, which could ...

PCOD and PCOS, common hormonal disorders in women, differ in severity and long-term impacts. PCOD, often lifestyle-related, ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Polycystic ovary syndrome is so fundamentally misunderstood, patients, researchers and medical professionals the world over are trying to change its name, with the effort led by Australian medical ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.

While embarking on her dreamy Grecian holiday, Anna May couldn't have been more excited. But then, she woke up with a pain she has since likened to 'full-blown labour' ...

Hormonal imbalances are among the most common health concerns for women today, and two terms often heard in this regard are PCOD (Polycystic Ovarian Disease) and PCOS (Polycystic Ovarian Syndrome).

US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.